Sofía Bruni
Impact in
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Cells and Metastasis
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in ⓘ
-
- Immunotherapy and Immune Responses 6
- Immune Response and Inflammation 2
- Immune cells in cancer 2
- Oncology 9
- HER2/EGFR in Cancer Research 4
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- María F. Mercogliano (11 shared papers)Roxana Schillaci (12 shared papers)Patricia V. Elizalde (8 shared papers)Rosalía I. Cordo Russo (6 shared papers)Elaine R. Mardis (1 shared paper)Renier J. Brentjens (1 shared paper)Theresa A. Proia (1 shared paper)Sašo Čemerski (1 shared paper)
- Journals
- Cancer Research (4 papers)Cancers (2 papers)Frontiers in Oncology (2 papers)Translational Oncology (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ArgentinaUnited StatesMalta
In The Last Decade
Sofía Bruni
12 papers receiving 377 citations
Peers
Comparison fields: 5 of 73
- Oncology 193
- Immunology 131
- Cancer Research 56
- Molecular Biology 130
- Radiology, Nuclear Medicine and Imaging 37
Countries citing papers authored by Sofía Bruni
This map shows the geographic impact of Sofía Bruni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofía Bruni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofía Bruni more than expected).
Fields of papers citing papers by Sofía Bruni
This network shows the impact of papers produced by Sofía Bruni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofía Bruni. The network helps show where Sofía Bruni may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofía Bruni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 121 | |
| 2 | 2023 | 83 | |
| 3 | 2021 | 76 | |
| 4 | 2020 | 43 | |
| 5 | 2023 | 23 | |
| 6 | 2020 | 18 | |
| 7 | 2022 | 9 | |
| 8 | 2019 | 4 | |
| 9 | 2022 | 3 | |
| 10 | 2025 | 1 | |
| 11 | 2022 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2022 | 0 |
About Sofía Bruni
Sofía Bruni is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Molecular Biology, having authored 13 papers that have together received 383 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Immunotherapy and Immune Responses (6 papers), Glycosylation and Glycoproteins Research (5 papers), HER2/EGFR in Cancer Research (4 papers), Immune Response and Inflammation (2 papers), CAR-T cell therapy research (2 papers), Immune cells in cancer (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (193 citations), Immunology (131 citations), Cancer Research (56 citations), Molecular Biology (130 citations) and Radiology, Nuclear Medicine and Imaging (37 citations). Sofía Bruni has collaborated with scholars based in Argentina, United States and Malta. Frequent co-authors include María F. Mercogliano, Roxana Schillaci, Patricia V. Elizalde, Rosalía I. Cordo Russo, Elaine R. Mardis, Renier J. Brentjens, Theresa A. Proia, Sašo Čemerski, Cecilia J. Proietti and Catherine M. Bollard. Their work appears in journals such as Cancer Research, Cancers, Frontiers in Oncology, Translational Oncology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.